ENDV (Endonovo Therapeutics) Buyback Yield %: -22.65 (As of Jun. 28, 2026)


What is Endonovo Therapeutics Buyback Yield %?

Endonovo Therapeutics ENDV -99.00% Buyback Yield % is -22.65 as of Jun. 28, 2026. The stock has 3 warning signs investors should review. Among 743 Biotechnology companies, Endonovo Therapeutics ranks worse than 69.85% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Endonovo Therapeutics's current buyback yield was -22.65%.

Endonovo Therapeutics Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics Buyback Yield % Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.28 -10.84 -3.70 -0.40 -45.05

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.41 47.64 -45.05 -37.80 -21.24

ENDV vs RGBP, IOBTQ, CNBX: Buyback Yield % Comparison

For the Biotechnology subindustry, Endonovo Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endonovo Therapeutics Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Endonovo Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Endonovo Therapeutics's Buyback Yield % falls into.


Endonovo Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Endonovo Therapeutics's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0.098) / 0.2175484
=-45.05%

Endonovo Therapeutics's annualized Buyback Yield for the quarter that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0.041) / 0.19305824
=-21.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -22.65 mean?
Endonovo Therapeutics (ENDV) has a Buyback Yield % of -22.65 as of Jun. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Endonovo Therapeutics and its competitors. According to the industry distribution chart, Endonovo Therapeutics ranks #519 out of 743 companies in the Biotechnology industry, placing it in the top 69.9%.
Is Endonovo Therapeutics' Buyback Yield % too high?
Endonovo Therapeutics' current Buyback Yield % is -22.65. Based on the distribution chart, Endonovo Therapeutics ranks #519 out of 743 companies in the Biotechnology industry, which is below the industry midpoint.
How does Endonovo Therapeutics' Buyback Yield % compare to RGBP and IOBTQ?
According to the Biotechnology industry distribution chart, Endonovo Therapeutics ranks #519 out of 743 companies for Buyback Yield %. This places Endonovo Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current Buyback Yield % is -22.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current Buyback Yield % of -22.65. The current Buyback Yield % is -22.65. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current Buyback Yield % is -22.65 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.